Patients with schizophrenia have increased mortality and morbidity compared with the
general population. These patients have a 20-year shorter lifespan than peers without …

Cardiovascular disease (CVD), which includes coronary heart, cerebrovascular, and
peripheral vascular disease, is the leading cause of death in the United States and most …

Objective: To provide an overview for practicing clinicians on the pharmacological basis of
cardiometabolic risk induced by antipsychotic drugs in patients with serious mental illness …

OBJECTIVE: Standardized mortality rates are elevated in schizophrenia compared to the
general population. The incidence of coronary heart disease (CHD) and the relative …

OBJECTIVE: The aim of the study is to review the absolute and relative impacts of the major
causes for premature mortality among patients with schizophrenia. DATA SOURCES: We …

Importance The fact that individuals with schizophrenia have high cardiovascular morbidity
and mortality is well established. However, risk status and moderators or mediators in the …

Cardiovascular morbidity and mortality are important problems among patients with
schizophrenia. A wide spectrum of reasons, ranging from genes to the environment, are held …

Individuals with serious mental illness experience excess morbidity and mortality, including
an increased prevalence of diabetes mellitus and cardiovascular disease. Cardiovascular …

Objective: To determine the prevalence and characteristics of coronary heart disease (CHD)
risk factors in patients with chronic schizophrenia or schizoaffective disorder. Method: We …

Cardiovascular aspects of antipsychotics : Current Opinion in Psychiatry Cardiovascular
aspects of antipsychotics : Current Opinion in Psychiatry Log in or Register Subscribe to …